ACTIVE

ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result13,9 M €+3,2 %over 1 year
Revenue270,4 M €-3,2 %over 1 year
Equity5 M €-1,9 %over 1 year
Workforce32,8 ETP+1,2 %over 1 year

Identity

Source · BCE/KBO

ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES is a Public limited company incorporated in 2007. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Mont-Saint-Guibert. It employs on average 32,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0888.210.786
Incorporation
22/03/2007
Legal form
Public limited company
Registered office
Rue Emile Francqui 3
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital
4 300 000,00 €
Latest accounts
31/12/2025
Average workforce
32,8 ETP
Joint committees (1)
  • 207
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 6 financial years

20252024202220212020
Income statement
Revenue270,4 M €279,4 M €233,5 M €185,7 M €139,7 M €
EBITDA17,8 M €18,8 M €15,6 M €12,8 M €9,1 M €
Operating result17,7 M €18,8 M €15,6 M €12,8 M €9,1 M €
Net result13,9 M €13,5 M €11,4 M €9,1 M €6,8 M €
Balance sheet
Equity5 M €5,1 M €5,3 M €13,9 M €4,8 M €
Total assets57,4 M €58,8 M €56,1 M €41,6 M €41,9 M €
Debts52,3 M €53,7 M €50,7 M €27,7 M €37,1 M €
Other
Workforce32,8 ETP32,4 ETP31,5 ETP31,8 ETP28,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 2 ended

Active mandates

Benoit LESSIRE

Chairman of the board of directors · since 17 juillet 2019 · until 30 juin 2026

Active
Sebastien DELPORTE

Director · since 17 juillet 2019 · until 30 juin 2026

Active

Ended mandates

Benoit LESSIRE

Chairman of the board of directors · since 17 juillet 2019 · until 30 juin 2020

Ended
Sebastien DELPORTE

Director · since 17 juillet 2019 · until 30 juin 2020

Ended

Other companies at this address

Rue Emile Francqui 3 1435 Mont-Saint-Guibert
CompanyCBE no.
BALENCIO● Active
0662.639.464
EverFlourish Belgium● Active
1038.501.301
Metronom Health Europe● Bankrupt
0664.816.818
OpenWAY Europe● Active
0475.304.156

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/07/202629/07/202531/07/202426/07/202326/07/202220/07/2021
General meeting30/06/202630/06/202528/06/202430/06/202330/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202622/07/2026FrenchPDF
Full model31/12/202430/06/202529/07/2025FrenchPDF
Full model31/12/202328/06/202431/07/2024FrenchPDF
Full model31/12/202230/06/202326/07/2023FrenchPDF
Full model31/12/202130/06/202226/07/2022FrenchPDF
Full model31/12/202030/06/202120/07/2021FrenchPDF
Full model31/12/201930/06/202018/08/2020FrenchPDF
Full model31/12/201817/07/201926/07/2019FrenchPDF
Full model31/12/201729/06/201830/07/2018FrenchPDF
Full model31/12/201630/06/201726/07/2017FrenchPDF
Full model31/12/201530/06/201614/07/2016FrenchPDF
Full model31/12/201431/07/201510/09/2015FrenchPDF
Full model31/12/201323/09/201422/10/2014FrenchPDF
Full model31/12/201225/10/201305/12/2013FrenchPDF
Full model31/12/201130/08/201206/09/2012FrenchPDF
Full model31/12/201019/10/201127/10/2011FrenchPDF
Full modelCorrection31/12/200926/05/201008/12/2010FrenchPDF
Full model31/12/200926/05/201026/10/2010FrenchPDF
Full model31/12/200816/11/200912/01/2010FrenchPDF
Full model31/12/200710/10/200801/12/2008FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 2 ended

Active mandates

Benoit LESSIRE

Chairman of the board of directors · since 17 juillet 2019 · until 30 juin 2026

Active
Sebastien DELPORTE

Director · since 17 juillet 2019 · until 30 juin 2026

Active

Ended mandates

Benoit LESSIRE

Chairman of the board of directors · since 17 juillet 2019 · until 30 juin 2020

Ended
Sebastien DELPORTE

Director · since 17 juillet 2019 · until 30 juin 2020

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates21/08/2026
    Renouvellement du mandat des administrateurs
    PDF
  • Mandates26/08/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Other04/09/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates11/08/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/10/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates30/01/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/08/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/08/2018
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202513,9 M €↑
  2. 30/06/2025
    nominationCarlo-Sébastien D'Addario — commissaire (représentant permanent)
  3. 2024
    Annual accounts 202413,5 M €↑
  4. 2022
    Annual accounts 202211,4 M €↑
  5. 30/06/2022
    reconductionEY Réviseurs d'Entreprises — commissaire
  6. 2021
    Annual accounts 20219,1 M €↑
  7. 2020
    Annual accounts 20206,8 M €↑
  8. 2019
    Annual accounts 20195,8 M €
  9. 22/03/2007
    IncorporationPublic limited company